Brokers Issue Forecasts for Astrana Health FY2024 Earnings

Astrana Health, Inc. (NASDAQ:ASTH) – Stock analysts at William Blair reduced their FY2024 earnings estimates for Astrana Health in a research report issued on Thursday, November 7th. William Blair analyst R. Daniels now forecasts that the company will post earnings per share of $1.10 for the year, down from their previous forecast of $1.18. The consensus estimate for Astrana Health’s current full-year earnings is $1.31 per share. William Blair also issued estimates for Astrana Health’s Q2 2025 earnings at $0.30 EPS, Q3 2025 earnings at $0.34 EPS and FY2025 earnings at $1.24 EPS.

ASTH has been the subject of several other reports. Stifel Nicolaus raised their price objective on shares of Astrana Health from $48.00 to $60.00 and gave the stock a “buy” rating in a report on Thursday, August 1st. BTIG Research raised their price objective on shares of Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a report on Thursday, October 3rd. Robert W. Baird raised their price objective on shares of Astrana Health from $54.00 to $67.00 and gave the stock an “outperform” rating in a report on Thursday, August 15th. Truist Financial raised their target price on shares of Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a research note on Friday, August 9th. Finally, KeyCorp began coverage on shares of Astrana Health in a research note on Friday, October 11th. They set a “sector weight” rating for the company. One analyst has rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, Astrana Health has a consensus rating of “Buy” and an average target price of $62.00.

Astrana Health Stock Performance

Shares of ASTH opened at $46.96 on Monday. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.84 and a quick ratio of 1.84. Astrana Health has a one year low of $29.63 and a one year high of $63.20. The company has a 50-day simple moving average of $55.51 and a two-hundred day simple moving average of $47.61. The firm has a market capitalization of $2.30 billion, a PE ratio of 32.61, a price-to-earnings-growth ratio of 2.27 and a beta of 1.24.

Institutional Investors Weigh In On Astrana Health

Institutional investors and hedge funds have recently made changes to their positions in the company. Summit Global Investments bought a new stake in shares of Astrana Health during the third quarter valued at approximately $753,000. Louisiana State Employees Retirement System bought a new stake in shares of Astrana Health during the third quarter valued at approximately $1,165,000. F M Investments LLC bought a new stake in shares of Astrana Health during the third quarter valued at approximately $11,738,000. SteelPeak Wealth LLC purchased a new stake in Astrana Health in the third quarter worth approximately $39,398,000. Finally, Guidance Capital Inc. purchased a new stake in Astrana Health in the third quarter worth approximately $724,000. Institutional investors own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.